Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 19/20 | 0.61 |
| ▸ | CNR1 | P21554 | 9/20 | 0.61 |
| ▸ | PIM1 | P11309 | 1/20 | 0.45 |
| ▸ | CLK2 | P49760 | 1/20 | 0.45 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13989848 | 0.89 | CNR2 (0.77) | CNR2CNR1 | |
| SCHEMBL13989585 | 0.89 | CNR2 (0.62) | CNR2CNR1 | |
| SCHEMBL13989601 | 0.88 | CNR2 (0.64) | CNR2CNR1 | |
| SCHEMBL943415 | 0.88 | CNR2 (0.57) | CNR2CNR1 | |
| SCHEMBL943413 | 0.88 | CNR2 (0.57) | CNR2CNR1 | |
| SCHEMBL13989574 | 0.88 | CNR2 (0.62) | CNR2CNR1PIM1CLK2CLK4 | |
| SCHEMBL13989589 | 0.85 | CNR2 (0.56) | CNR2CNR1 | |
| SCHEMBL3387251 | 0.85 | CNR2 (0.63) | CNR2CNR1 | |
| SCHEMBL3387243 | 0.85 | CNR2 (0.63) | CNR2CNR1 | |
| SCHEMBL3384557 | 0.84 | PIM1 (0.63) | CNR2CNR1PIM1CLK2CLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080312435-A1 | Imine Compound | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2008-12-18 | — | — | US | disclosed |
| US-20080312435-A1 | Imine Compound | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312435-A1 | Imine Compound | CNR1, CNR2, HRH4 | CNR2 2/4885CNR1 1/4885PIM1 1653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.